PET imaging of brain amyloid in dementia: a review (Q37929674)

25 August 2017

1 reference

title

PET imaging of brain amyloid in dementia: a review (English)

1 reference

25 August 2017

0 references

3

1 reference

25 August 2017

Harriet Quigley

1

0 references

author name string

Sean J Colloby

series ordinal

2

1 reference

PubMed ID

21905095

25 August 2017

language of work or name

English

0 references

publication date

28 December 2010

1 reference

International Journal of Geriatric Psychiatry

25 August 2017

1 reference

25 August 2017

26

1 reference

25 August 2017

991-999

1 reference

25 August 2017

10

1 reference

In vitro detection of (S)-naproxen and ibuprofen binding to plaques in the Alzheimer's brain using the positron emission tomography molecular imaging probe 2-(1-[6-[(2-[(18)F]fluoroethyl)(methyl)amino]-2-naphthyl]ethylidene)malononitrile

25 August 2017

1 reference

Frequent amyloid deposition without significant cognitive impairment among the elderly

21 January 2018

1 reference

Amyloid load and cerebral atrophy in Alzheimer's disease: an 11C-PIB positron emission tomography study.

21 January 2018

1 reference

Differences in neuropathologic characteristics across the Lewy body dementia spectrum.

21 January 2018

1 reference

Neuropathology of older persons without cognitive impairment from two community-based studies

21 January 2018

1 reference

Neuropathological stageing of Alzheimer-related changes

21 January 2018

1 reference

Imaging amyloid in Parkinson's disease dementia and dementia with Lewy bodies with positron emission tomography

21 January 2018

1 reference

In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia

21 January 2018

1 reference

Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study.

21 January 2018

1 reference

Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography.

21 January 2018

1 reference

Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.

21 January 2018

1 reference

In vivo amyloid imaging with PET in frontotemporal dementia.

21 January 2018

1 reference

PET imaging of amyloid deposition in patients with mild cognitive impairment.

21 January 2018

1 reference

Development of an anti-A beta monoclonal antibody for in vivo imaging of amyloid angiopathy in Alzheimer's disease.

21 January 2018

1 reference

Differing patterns of temporal atrophy in Alzheimer's disease and semantic dementia.

21 January 2018

1 reference

Imaging amyloid deposition in Lewy body diseases

21 January 2018

1 reference

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

21 January 2018

1 reference

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

21 January 2018

1 reference

Alzheimer's disease: the amyloid cascade hypothesis

21 January 2018

1 reference

Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease

21 January 2018

1 reference

11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment

21 January 2018

1 reference

Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease

21 January 2018

1 reference

Imaging of amyloid burden and distribution in cerebral amyloid angiopathy.

21 January 2018

1 reference

PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment.

21 January 2018

1 reference

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

21 January 2018

1 reference

The future of amyloid-beta imaging: a tale of radionuclides and tracer proliferation

21 January 2018

1 reference

Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees

21 January 2018

1 reference

PET amyloid ligand [11C]PIB uptake and cerebrospinal fluid beta-amyloid in mild cognitive impairment

21 January 2018

1 reference

Clinical applications of PET amyloid imaging: an update.

21 January 2018

1 reference

Reversible in vitro growth of Alzheimer disease beta-amyloid plaques by deposition of labeled amyloid peptide

21 January 2018

1 reference

Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents

21 January 2018

1 reference

Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects

21 January 2018

1 reference

Mild cognitive impairment represents early-stage Alzheimer disease

21 January 2018

1 reference

PET imaging of amyloid in Alzheimer's disease.

21 January 2018

1 reference

Amyloid imaging in Alzheimer's disease.

21 January 2018

1 reference

Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease

21 January 2018

1 reference

Molecular targeting of Alzheimer's amyloid plaques for contrast-enhanced magnetic resonance imaging

21 January 2018

1 reference

Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B.

21 January 2018

1 reference

11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration.

21 January 2018

1 reference

Amyloid imaging in aging and dementia: testing the amyloid hypothesis in vivo

21 January 2018

1 reference

Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease

21 January 2018

1 reference

Imaging of amyloid beta in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism

21 January 2018

1 reference

Imaging beta-amyloid burden in aging and dementia.

21 January 2018

1 reference

PET of brain amyloid and tau in mild cognitive impairment.

21 January 2018

1 reference

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

21 January 2018

1 reference

Phases of A beta-deposition in the human brain and its relevance for the development of AD.

21 January 2018

1 reference

Abeta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease.

21 January 2018

1 reference

The magnitude of dementia occurrence in the world

21 January 2018

1 reference

Update on amyloid imaging: from healthy aging to Alzheimer's disease

21 January 2018

1 reference

Amyloid imaging in mild cognitive impairment subtypes.

21 January 2018

1 reference

Structure-activity relationship of imidazo[1,2-a]pyridines as ligands for detecting beta-amyloid plaques in the brain

21 January 2018

1 reference

Potential for imaging cerebral amyloid deposits using 123I-labelled serum amyloid P component and SPET.

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

PIB is a non-specific imaging marker of amyloid-beta (Abeta) peptide-related cerebral amyloidosis

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

[11C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/GPS.2640

1 reference

25 August 2017

1 reference

PubMed ID

21905095